There has been substantial research interest in delivering therapeutic neurotrophic factors directly to the brain for the treatment of Parkinson's Disease (PD) and other movement disorders. Direct infusion of glial cell-line derived neurotrophic factor has been investigated in both pre-clinical models and clinical trials. In this chapter we discuss past and present research investigating the potential of direct drug delivery to the brain for the treatment of PD and other movement disorders.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000481108 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!